Search Results - "Pelham, Christopher J."

Refine Results
  1. 1

    Cell competition in tumor evolution and heterogeneity: Merging past and present by Pelham, Christopher J., Nagane, Masaki, Madan, Esha

    Published in Seminars in cancer biology (01-06-2020)
    “…In many cases, cancers are difficult to eliminate because they develop resistance to a primary chemotherapy or targeted therapy. Tumors grow into diverse cell…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cullin-3 Regulates Vascular Smooth Muscle Function and Arterial Blood Pressure via PPARγ and RhoA/Rho-Kinase by Pelham, Christopher J., Ketsawatsomkron, Pimonrat, Groh, Séverine, Grobe, Justin L., de Lange, Willem J., Ibeawuchi, Stella-Rita C., Keen, Henry L., Weatherford, Eric T., Faraci, Frank M., Sigmund, Curt D.

    Published in Cell metabolism (03-10-2012)
    “…Dominant-negative (DN) mutations in the nuclear hormone receptor peroxisome proliferator-activated receptor-γ (PPARγ) cause hypertension by an unknown…”
    Get full text
    Journal Article
  4. 4

    Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells by Ikhapoh, Izuagie Attairu, Pelham, Christopher J., Agrawal, Devendra K.

    Published in Differentiation (London) (01-03-2015)
    “…Mesenchymal stem cells (MSC) have shown therapeutic potential to engraft and either differentiate into or support differentiation of vascular endothelial cells…”
    Get full text
    Journal Article
  5. 5

    Atherogenic Cytokines Regulate VEGF-A-Induced Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells into Endothelial Cells by Ikhapoh, Izuagie Attairu, Agrawal, Devendra K., Pelham, Christopher J.

    Published in Stem Cells International (01-01-2015)
    “…Coronary artery stenting or angioplasty procedures frequently result in long-term endothelial dysfunction or loss and complications including arterial…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Emerging roles for triggering receptor expressed on myeloid cells receptor family signaling in inflammatory diseases by Pelham, Christopher J, Agrawal, Devendra K

    Published in Expert review of clinical immunology (01-02-2014)
    “…Innate immune receptors represent important therapeutic targets for inflammatory disorders. In particular, the Toll-like receptor (TLR) family has emerged as a…”
    Get more information
    Journal Article
  8. 8

    Vitamin D Controls Resistance Artery Function through Regulation of Perivascular Adipose Tissue Hypoxia and Inflammation by Pelham, Christopher J, Drews, Elizabeth M, Agrawal, Devendra K

    “…Abstract Vitamin D deficiency in human subjects is associated with hypertension, metabolic syndrome and related risk factors of cardiovascular diseases. Serum…”
    Get full text
    Journal Article
  9. 9

    Triggering receptor expressed on myeloid cells receptor family modulators: a patent review by Pelham, Christopher J, Pandya, Amit N, Agrawal, Devendra K

    Published in Expert opinion on therapeutic patents (01-12-2014)
    “…Triggering receptor expressed on myeloid cells (TREM) receptors and TREM-like transcript (TLT; or TREML) receptors of the immunoglobulin superfamily are known…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation by De Silva, T Michael, Modrick, Mary L, Ketsawatsomkron, Pimonrat, Lynch, Cynthia, Chu, Yi, Pelham, Christopher J, Sigmund, Curt D, Faraci, Frank M

    Published in Hypertension (Dallas, Tex. 1979) (01-11-2014)
    “…Although peroxisome proliferator-activated receptor-γ (PPARγ) is thought to play a protective role in the vasculature, its cell-specific effect, particularly…”
    Get full text
    Journal Article
  13. 13

    PPARγ Regulates Resistance Vessel Tone Through a Mechanism Involving RGS5-Mediated Control of Protein Kinase C and BKCa Channel Activity by Ketsawatsomkron, Pimonrat, Lorca, Ramón A, Keen, Henry L, Weatherford, Eric T, Liu, Xuebo, Pelham, Christopher J, Grobe, Justin L, Faraci, Frank M, England, Sarah K, Sigmund, Curt D

    Published in Circulation research (09-11-2012)
    “…RATIONALE:Activation of peroxisome proliferator−activated receptor-γ (PPARγ) by thiazolidinediones lowers blood pressure, whereas PPARγ mutations cause…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells by Ikhapoh, Izuagie Attairu, Pelham, Christopher J, Agrawal, Devendra K

    Published in Stem cell research & therapy (06-01-2015)
    “…Increased levels of angiotensin II (Ang II) and activity of Ang II receptor type 1 (AT1R) elicit detrimental effects in cardiovascular disease. However, the…”
    Get full text
    Journal Article
  16. 16

    Does Peroxisome Proliferator-activated Receptor-γ (PPARγ) Protect from Hypertension Directly through Effects in the Vasculature? by Ketsawatsomkron, Pimonrat, Pelham, Christopher J., Groh, Séverine, Keen, Henry L., Faraci, Frank M., Sigmund, Curt D.

    Published in The Journal of biological chemistry (26-03-2010)
    “…Peroxisome proliferator-activated receptor-γ (PPARγ) is a ligand-activated transcription factor of the nuclear hormone receptor superfamily. Increasing…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Pregnant mice lacking indoleamine 2,3‐dioxygenase exhibit preeclampsia phenotypes by Santillan, Mark K., Pelham, Christopher J., Ketsawatsomkron, Pimonrat, Santillan, Donna A., Davis, Deborah R., Devor, Eric J., Gibson‐Corley, Katherine N., Scroggins, Sabrina M., Grobe, Justin L., Yang, Baoli, Hunter, Steven K., Sigmund, Curt D.

    Published in Physiological reports (01-01-2015)
    “…Preeclampsia is a cardiovascular disorder of late pregnancy that is, commonly characterized by hypertension, renal structural damage and dysfunction, and fetal…”
    Get full text
    Journal Article
  19. 19

    Preservation of Intracellular Renin Expression Is Insufficient to Compensate for Genetic Loss of Secreted Renin by Xu, Di, Borges, Giulianna R, Grobe, Justin L, Pelham, Christopher J, Yang, Baoli, Sigmund, Curt D

    Published in Hypertension (Dallas, Tex. 1979) (01-12-2009)
    “…The primary product of the renin gene is preprorenin. A signal peptide sorts renin to the secretory pathway in juxtaglomerular cells where it is released into…”
    Get full text
    Journal Article
  20. 20